JPRN-UMIN000013428
Recruiting
Phase 2
Feasibility study of stereotactic body radiotherapy for metastatic vertebral body tumor - Feasibility study of SBRT for metastatic vertebral body tumor
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital0 sites20 target enrollmentMarch 14, 2014
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patient who cannot get MRI 2\) Patient who has uncontrolled collagen disease, cardiac disease, respiratory disease or liver disorders. 3\) Patient who has progressive neural symptom 4\) Lesion which has cord compression grade 2 or 3\. 5\) Lesion which has vertebral compression fracture. 6\) Patient who had chemotherapy with in 1 week before SBRT.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic CholangiocarcinomaCarcinoma, HepatocellularIntrahepatic CholangiocarcinomaNCT01668134Washington University School of Medicine28
Completed
N/A
Efficacy of stereotactic body radiotherapy in primary renal cell carcinomaKCT0007835Asan Medical Center40
Completed
Phase 1
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.lung tumorJPRN-UMIN000005061Department of Radiology, Nagoya City University Graduate School of Medical Sciences35
Withdrawn
N/A
Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerNCT02250378University of Southern California
Terminated
Phase 1
To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma TumorsPrimary TumorRenal Cell CarcinomaNCT02410174Beth Israel Medical Center3